12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 09/29 17:06
Gainers
- Stablecoin Development (AMEX:SDEV) stock increased by 121.6% to $3.48 during Tuesday's regular session. The market value of their outstanding shares is at $42.5 million.
- Iovance Biotherapeutics (NASDAQ:IOVA) shares rose 36.71% to $15.03. The market value of their outstanding shares is at $4.9 billion.
- Nautilus Biotechnology (NASDAQ:NAUT) shares moved upwards by 36.48% to $1.51. The company's market cap stands at $141.2 million.
- Silexion Therapeutics (NASDAQ:SLXN) shares rose 25.52% to $0.31. The market value of their outstanding shares is at $1.3 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock rose 24.89% to $0.12.
- Quantum-Si (NASDAQ:QSI) shares moved upwards by 22.66% to $0.98. The market value of their outstanding shares is at $174.0 million.
Losers
- NewGenIvf Group (NASDAQ:NIVF) stock fell 79.0% to $0.07 during Tuesday's regular session.
- BeyondSpring (NASDAQ:BYSI) stock decreased by 44.92% to $0.62. The market value of their outstanding shares is at $46.0 million.
- uniQure (NASDAQ:QURE) shares decreased by 36.77% to $24.73. The market value of their outstanding shares is at $2.7 billion.
- AIxCrypto Hldgs (NASDAQ:AIXC) stock decreased by 36.75% to $1.05. The market value of their outstanding shares is at $35.0 million.
- Onconetix (NASDAQ:ONCO) stock fell 27.92% to $0.8. The market value of their outstanding shares is at $4.8 million.
- Azitra (AMEX:AZTR) shares decreased by 22.9% to $0.13. The market value of their outstanding shares is at $10.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.